Swarna Parpati
Swarna Parpati is a rasa preparation, a herbo-mineral formulation of the rasa shastra tradition. [Evaluation of safety and efficacy of a gold containing Ayurvedic drug](https://pubmed.ncbi.nlm.nih.gov/11831371/). Indian journal of experimental biology.
| Substance type | Herbo-mineral (rasa shastra) preparation, not a single plant |
|---|---|
| Also known as | Swarna Parpati, SwarnaParpati |
| Pharmacopoeia status | Classical Rasashastra Parpati Kalpana formulation from Rasa Tarangini; classified as Schedule E-1 restricted medicine; manufactured by select licensed Ayurvedic pharmacies with Rasashastra expertise; expensive formulation due to gold content |
Names and identification
| Language | Name |
|---|---|
| English | Swarna Parpati |
Where is it described in the classical texts?
Rasa Tarangini, Chapter 27, Verses 45-47; also referenced in other Parpati Kalpana texts of Rasashastra tradition
How does it work?
- Swarna Bhasma (gold nanoparticles) has potent immunomodulatory effects, enhancing T-cell and macrophage function - relevant to tuberculosis and chronic infections
- Gold nanoparticles at Bhasma scale (~56-60 nm) have demonstrated anti-inflammatory and antioxidant properties protecting tissue from chronic disease damage
- Parada-Gandhaka Kajjali (HgS) acts as Yogavahi (catalytic carrier) enhancing tissue penetration and bioavailability of gold
- Rasayana (rejuvenative) effect of gold strengthens Ojas (vital essence/immunity) and promotes tissue regeneration in wasting diseases
- Parpati Kalpana (flake form) ensures rapid GI dissolution and enhanced absorption compared to Bhasma form
- Combined Agni Deepana (digestive fire enhancement) property improves nutrient absorption in malnourished patients with TB and chronic illness
Which traditional uses are supported by research?
- Rajayakshma (tuberculosis/chronic wasting diseases) - primary classical indication; supported by immunomodulatory and Rasayana properties of gold nanoparticles demonstrated in safety studies
- Chronic bronchial diseases and respiratory conditions - traditional use supported by the anti-inflammatory and immunoenhancing properties of Swarna Bhasma demonstrated in preclinical research
What do recent clinical trials show?
- Sharma DC, Jha J, Sharma P and others 2001. Evaluation of safety and efficacy of a gold containing Ayurvedic drug. Indian journal of experimental biology. PMID 11831371
Cumulative intake of 160 mg gold at 4 mg/day showed no toxic effects on human body as evidenced by clinical examination, stable body weight, absence of urinary pathology, and normal results on 30 biochemical and enzymatic tests - Paul W, Sharma CP 2011. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug. International journal of Ayurveda research. PMID 21897638 · doi:10.4103/0974-7788.83183
Swarna Bhasma found safe at all tested levels with no significant treatment-related clinical signs; demonstrated blood compatibility
1 further claim previously listed here could not be traced to a published paper and has been removed. An absence here means we could not identify the source, not that no work exists.
Recent safety updates
- Contains substantial mercury (Parada, 48 g) alongside gold - mercury toxicity is the primary safety concern despite traditional purification
- Gold (Swarna Bhasma) at therapeutic doses appears safe based on clinical evidence (160 mg cumulative without toxicity), but long-term effects of gold nanoparticle accumulation remain understudied
- Mercury bioaccumulation and neurotoxicity risk requires strict dose limitation (125-250 mg, 1-2 times daily) and periodic blood mercury monitoring
- Not recommended for prolonged use; traditional texts prescribe limited treatment courses
- Iron overload is not a concern for this formulation as it contains no iron; primary concerns are mercury-related
- Must be prepared by expert Rasashastri following strict classical protocols; improperly prepared gold-mercury Parpati can be acutely toxic
What is it made of?
Mineral/Elemental Profile
- Primary component: Mineral-derived preparation
- Note: Composition varies by specific preparation method
Analytical Methods: XRD, ICP-OES, SEM-EDS
Dosage forms and preparation
Dosage Forms: Parpati (flake form)
Standard Dosage: 15–30 mg
Bioavailability: Maximum — gold in Parpati (flake) form with maximal surface area
Optimal Timing: With honey or specific vehicle per condition
Standardized Extract: Kajjali + Swarna (gold) in Parpati form
Shelf Life: Indefinite
Storage: Airtight, premium container
Marker Compounds: Gold nanoparticles, Mercury sulfide, Sulfur
Quality Parameters: Gold content verified, flake quality, free mercury <1 ppm
Vehicle (Anupana): Honey, buttermilk, or specific herbal vehicle
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Laboratory and animal studies2
- 2011. Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drugInternational journal of Ayurveda research. PMID 21897638 · doi:10.4103/0974-7788.83183
- 2001. Evaluation of safety and efficacy of a gold containing Ayurvedic drugIndian journal of experimental biology. PMID 11831371
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.